780
Participants
Start Date
January 31, 1998
Primary Completion Date
November 30, 2001
doxorubicin hydrochloride
ifosfamide
National Institute of Oncology, Budapest
Rigshospitalet, Copenhagen
Centre Leon Berard, Lyon
Universitair Ziekenhuis Antwerpen, Edegem
U.Z. Gasthuisberg, Leuven
Aarhus Kommunehospital, Aarhus
Institut Gustave Roussy, Villejuif
Medizinische Hochschule Hannover, Hanover
Klinikum Grosshadern, Munich
Antoni van Leeuwenhoekhuis, Amsterdam
Leiden University Medical Center, Leiden
University Medical Center Nijmegen, Nijmegen
Rotterdam Cancer Institute, Rotterdam
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw
National Cancer Institute - Bratislava, Bratislava
Hospital Insular de Gran Canaria, Las Palmas
St. James's Hospital, Leeds
Royal Marsden NHS Trust, London
Middlesex Hospital- Meyerstein Institute, London
Christie Hospital N.H.S. Trust, Manchester
Newcastle General Hospital, Newcastle upon Tyne
Nottingham City Hospital NHS Trust, Nottingham
Weston Park Hospital, Sheffield
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK